| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lymphogranuloma Venereum (LGV) Differentiation Antibody Panel, MIF
Test Code19553
CPT Codes
86631 (x8), 86632 (x4)
Includes
C. trachomatis L1 Ab (IgG, IgA, IgM)
C. trachomatis D-K Ab (IgG, IgA, IgM)
C. pneumoniae Ab (IgG, IgA, IgM)
C. psittaci Ab (IgG, IgA, IgM)
C. trachomatis D-K Ab (IgG, IgA, IgM)
C. pneumoniae Ab (IgG, IgA, IgM)
C. psittaci Ab (IgG, IgA, IgM)
Preferred Specimen
1 mL serum
Minimum Volume
0.2 mL
Instructions
Serum: Collect in a serum separator tube or red-top tube (no gel). The tube should be centrifuged after clotting. Spun serum separator tubes may be submitted at room temperature or refrigerated unopened without transfer to a plastic screw-cap vial. Red-top tube (no gel) serum should be transferred to a plastic screw-cap vial and submitted for testing.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric • Samples submitted in original red-top tube(no gel)
Methodology
Micro-Immunofluorescence (MIF)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sat; Report available: 1-3 days
Clinical Significance
Lymphogranuloma venerum (LGV) is a clinical syndrome caused by infection with C. trachomatis which typically includes genital bubonic disease. The serologic detection of C. trachomatis infection is complicated by the presence of crossreactive antibody to other Chlamydia species or nonspecific stimulation of anti-Chlamydia Ab. To differentiate C. trachomatis infection from other Chlamydia species, a panel of Chlamydia is tested for the determination of specific antibody titers.
